KIAA1429

August 21, 2023

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy

Abstract Background: KIAA1429, also known as VIRMA (vir-like m6A methyltransferase associated), plays a crucial role in tumorigenesis by modulating the…

December 16, 2022

Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma

Abstract Background: Lung adenocarcinoma (LUAD) is the most common lung cancer worldwide. N6‐methyladenosine (m6A) methylation is a messenger RNA (mRNA)…

March 17, 2021

Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)

Abstract N6-Methyladenosine (m6A) modification is one of the most widely distributed RNA modifications in eukaryotes. It participates in various RNA…